Related Experiment Video

Updated: May 27, 2026

Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis
07:51

Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis

Published on: September 26, 2018

[Stratification-system of cardiovascular risk in JSH2009]

Shigeyuki Saitoh1

  • 1Second Department of Internal Medicine, Sapporo Medical University School of Medicine.

Nihon Rinsho. Japanese Journal of Clinical Medicine
|November 25, 2011
PubMed

Insights

The Japanese Society of Hypertension (JSH2009) risk stratification system effectively predicts cardiovascular events in hypertension management. This study validates its utility and accuracy for clinical practice.

Area of Science:

  • Cardiology
  • Public Health
  • Epidemiology

Context:

  • The Japanese Society of Hypertension (JSH) released guidelines in 2009 (JSH2009) for hypertension management.
  • These guidelines utilize a risk stratification system based on cardiovascular prognosis to guide treatment strategies.
  • The clinical utility and validity of this specific risk stratification system required examination.

Purpose:

  • To assess the utility and validity of the JSH2009 risk stratification system.
  • To determine if the JSH2009 system accurately predicts cardiovascular events.
  • To evaluate the system's applicability in real-world hypertension management.

Summary:

  • A study involving 2,000 residents from the Tanno-Sobetsu cohort, with no prior cardiovascular events or hypertension medication, was conducted.
  • Participants were followed for 13 years, during which cardiovascular events were monitored.
  • Analysis revealed a statistically significant linear increase in cardiovascular events correlating with higher risk stratification levels defined by JSH2009.

Impact:

  • The findings confirm the utility and validity of the JSH2009 risk stratification system for hypertension management.
  • This validated system can aid clinicians in stratifying cardiovascular risk more accurately.
  • The study supports the use of JSH2009 for improved patient outcomes in hypertensive individuals.

Related Concept Videos

Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Blood Studies for Cardiovascular System III: Serum Lipid Profile01:25

Blood Studies for Cardiovascular System III: Serum Lipid Profile

Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Cardiovascular Drugs: Classification based on Therapeutic Indications01:18

Cardiovascular Drugs: Classification based on Therapeutic Indications

Cardiovascular diseases, encompassing a range of conditions, can significantly affect the heart's operations and the overall circulatory system. These conditions impair the heart's ability to pump blood, leading to a deficit in oxygen supply to crucial organs. Anomalies in the heart's electrical system, known as arrhythmias, can cause heartbeats to accelerate or slow down. Usually, heart rates increase during physical activity and decrease while resting or sleeping. However, frequent irregular...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...